Role of Canagliflozin on gene expression and function of CD34+ endothelial progenitor cells in patients with type 2 diabetes and mild chronic kidney disease (Stages 1-2, CKD)

We are looking to see if Invokana, an FDA Approved Type 2 Diabetes medication, can help improve kidney function and cardiovascular health. We are looking for patients aged 40-70 years with Type 2 Diabetes who are taking Metformin (1000-2000mg). Your HbA1C should be between 7 – 10 %.

Sponsor(s)
Janssen Pharmaceuticals, Inc.
Principal Investigator(s)
Sabyasachi Sen, MD/Endocrinology
Contact Phone Number
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

5 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.